ACE2 and SARS-CoV-2: Tissue or Plasma, Good or Bad?

Am J Hypertens. 2021 Apr 2;34(3):274-277. doi: 10.1093/ajh/hpaa175.

Authors

Ulrich O Wenzel¹, Ulrich Kintscher²

Affiliations

¹ Department of Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
² Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pharmacology, Center for Cardiovascular Research, Berlin, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angiotensin-Converting Enzyme 2* / blood
Angiotensin-Converting Enzyme 2* / metabolism
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
COVID-19* / blood
COVID-19* / metabolism
COVID-19* / virology
Cardiovascular Diseases* / drug therapy
Cardiovascular Diseases* / metabolism
Humans
Receptors, Virus / metabolism
Renin-Angiotensin System* / drug effects
Renin-Angiotensin System* / physiology
SARS-CoV-2 / physiology*
Virus Internalization / drug effects

Substances

Angiotensin-Converting Enzyme Inhibitors
Receptors, Virus
Angiotensin-Converting Enzyme 2